Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors

International Journal of Radiation Biology

Volumn 77, Issue 4, 2001, Pages 431-464

  Little, M P ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BATTLE INJURY; CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; FEMALE; HUMAN; IONIZING RADIATION; JAPAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RISK ASSESSMENT; SOLDIER; WAR;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; INCIDENCE; JAPAN; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; RADIOTHERAPY; RISK FACTORS;

EID: 0035070923     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/09553000010022634     Document Type: Article

References (115)

1. Cancer incidence among Danish Thorotrast-exposed patients
2. The radiosensitivity of human haemopoietic progenitor cells
3. Breast cancer and other second neoplasms after childhood Hodgkin's disease
4. Radiation and non-Hodgkin's lymphoma
5. Radiation dose and breast cancer risk in patients treated for cancer of the cervix
6. Radiation dose and leukemia risk in patients treated for cancer of the cervix
7. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries
8. Radiation dose and second cancer risk in patients treated for cancer of the cervix
9. Cancer in the contralateral breast after radiotherapy for breast cancer
10. Incidence of second cancers in patients treated for Hodgkin's disease
11. The inverse dose-rate effect for oncogenic transformation by neutrons and charged particles: A plausible interpretation consistent with published data
12. The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships
13. Effects of radiation on incidence of primary liver cancer among atomic bomb survivors
14. Summary: Multiple primary cancers in Connecticut, 1935-82
15. Risk of leukemia after chemotherapy and radiation treatment for breast cancer
16. Relationship of leukemia risk to radiation dose following cancer of the uterine corpus
17. A cohort study with regard to the risk of haematological malignancies in patients treated with X-rays for benign lesions in the locomotor system. I. Epidemiological analyses
18. Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica
19. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients
20. A review of human cell radiosensitivity in vitro
21. Breast cancer mortality after diagnostic radiography. Findings from the U.S. scoliosis cohort study
22. Benign and malignant thyroid nodules after neck irradiation
23. Tumors after radiotherapy for skin hemangioma in childhood. A casecontrol study
24. Some effects of random dose measurement errors on analyses of atomic bomb survivor data
25. Cancer following radiotherapy for peptic ulcer
26. Leukaemia incidence after iodine-131 exposure
27. Thyroid cancer after diagnostic administration of iodine-131
28. Breast cancer after treatment of Hodgkin's disease
29. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer
30. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer
31. The risk of breast cancer after irradiation of the thymus in infancy
32. Risk of extrathyroid tumors following radiation treatment in infancy for thymic enlargement
33. Breast cancer in women with scoliosis exposed to multiple diagnostic X rays
34. Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the atomic bomb survivors study
35. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study
36. Leukemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign disease
37. Cancer mortality following radium treatment for uterine bleeding
38. Lung cancer risk and radiation dose among women treated for breast cancer
39. Lung cancer following Hodgkin's disease: A case-control study
40. Leukemia following Hodgkin's disease
41. Intracranial tumors after exposure to ionizing radiation during infancy: A pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma
42. Incidence of salivary gland tumors among atomic bomb survivors, 1950-87. Evaluation of radiation-related risk
43. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease
44. Cancer incidence after radiotherapy for skin haemangioma during infancy
45. Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors
46. The risk of nonmelanoma skin cancer incidence in the Japanese atomic bomb survivors
47. Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors
48. Relative risks of radiationassociated cancer: Comparison of second cancer in therapeutically irradiated populations with the Japanese atomic bomb survivors
49. Variations with time and age in the relative risks of solid cancer incidence after radiation exposure
50. Risks of brain tumour following treatment for cancer in childhood: Modification by genetic factors, radiotherapy and chemotherapy
51. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis
52. Risk of solid tumors after irradiation in infancy
53. Mortality from leukemia after irradiation in infancy for skin hemangioma
54. Thyroid cancer after radiotherapy for skin hemangioma in infancy
55. Breast cancer risk after radiotherapy in infancy: A pooled analysis of two Swedish cohorts of 17,202 infants
56. Incidence of primary malignancies other than breast cancer among women treated with radiation therapy for benign breast disease
57. Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease
58. Clinically important radiation-associated thyroid disease. A controlled study
59. Increased risk of breast cancer after low-dose irradiation
60. Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950-1990
61. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data
62. Thyroid nodularity after childhood irradiation for lymphoid hyperplasia: A comparison of questionnaire and clinical findings
63. Cancer incidence in atomic bomb survivors. Part III: Leukemia, lymphoma and multiple myeloma, 1950-1987
64. Prior exposure to medical and dental X-rays related to tumors of the parotid gland
65. Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies
66. Mortality after radiotherapy for ringworm of the scalp
67. Tumors of the brain and nervous system after radiotherapy in childhood
68. Thyroid neoplasia following low-dose radiation in childhood
69. Radiation-induced skin carcinomas of the head and neck
70. Skin tumor risk among atomic-bomb survivors in Japan
71. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality
72. Dose-response relationships for female radium dial workers
73. The link between low-LET dose-response relations and the underlying kinetics of damage production/repair/misrepair
74. Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: Dose-response relationships
75. Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: Evidence for the prolonged effects of radiation on the thyroid
76. Skin cancer incidence among children irradiated for ringworm of the scalp
77. Thyroid cancer among persons given X-ray treatment in infancy for an enlarged thymus gland
78. Breast cancer among women given X-ray therapy for acute postpartum mastitis
79. Neurilemomas and salivary gland tumors of the head and neck following childhood irradiation
80. Cancer mortality among patients with ankylosing spondylitis not given X-ray therapy
81. Thyroid cancer incidence in the Ukraine after the Chernobyl accident: Comparison with spontaneous incidences
82. Adjuvant radiotherapy and risk of contralateral breast cancer
83. Breast cancer following multiple chest fluoroscopies among tuberculosis patients. A case-control study in Denmark
84. Tissue doses from radiotherapy of cancer of the uterine cervix
85. R
86. Use of external rates in nested case-control studies with application to the International Radiation Study of Cervical Cancer Patients
87. The US radium luminisers: A case for a policy of 'below regulatory concern'
88. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987
89. Treatment-associated leukemia following testicular cancer
90. Bone sarcomas linked to radiotherapy and chemotherapy in children
91. Leukemia after therapy with alkylating agents for childhood cancer
92. Therapeutic radiation at a young age is linked to secondary thyroid cancer
93. Radiation-induced skin cancer and radiodermatitis of the head and neck
94. Cancer mortality following X-ray treatment for ankylosing spondylitis
95. Leukemia mortality after X-ray treatment for ankylosing spondylitis
96. Effects on the thyroid in populations exposed to radiation as a result of the Chernobyl accident
97. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk